Does RUCAPARIB CAMSYLATE Cause Peripheral swelling? 180 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 180 reports of Peripheral swelling have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 2.2% of all adverse event reports for RUCAPARIB CAMSYLATE.
180
Reports of Peripheral swelling with RUCAPARIB CAMSYLATE
2.2%
of all RUCAPARIB CAMSYLATE reports
3
Deaths
25
Hospitalizations
How Dangerous Is Peripheral swelling From RUCAPARIB CAMSYLATE?
Of the 180 reports, 3 (1.7%) resulted in death, 25 (13.9%) required hospitalization.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 180 reports have been filed with the FAERS database.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Peripheral swelling Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE